Top Markets
Coin of the day
Bristol-Myers Squibb Company Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

BMY
Rang in aandelen #174
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity,... Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults. Other key therapies are Sprycel, employed in the management of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, indicated for patients with unresectable or metastatic melanoma; and Abraxane, a protein-bound chemotherapy formulation. Furthermore, Bristol-Myers Squibb offers Reblozyl, addressing anemia in adult patients with beta thalassemia; Empliciti, another treatment option for multiple myeloma; and Zeposia, designed to treat relapsing forms of multiple sclerosis. Revolutionary treatments like Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for adult patients battling relapsed or refractory large B-cell lymphoma, are also part of its lineup. Completing its product range are Inrebic, an oral kinase inhibitor specifically for adult myelofibrosis, and Onureg, used in the treatment of adult patients with acute myeloid leukemia (AML). Bristol-Myers Squibb distributes its pharmaceutical products through a diverse network encompassing wholesalers, distributors, pharmacies, retail outlets, hospitals, clinics, and governmental organizations. Founded in 1887 and formerly known as Bristol-Myers Company, the firm maintains its headquarters in New York, New York.
Aandeelprijs
$62.26
Laatst gesynchroniseerd: 2026-09-22
Marktkapitalisatie
$127.18B
Verandering (1 dag)
-0.78%
Verandering (1 jaar)
38.63%
Land
US
Handel Bristol-Myers Squibb Company (BMY)

Categorie

Dividendgeschiedenis van Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (aandelsymbool: BMY) heeft in totaal 214 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $48.98
Dividendrendement (TTM): 0.0392
Dividendbetalingen voor Bristol-Myers Squibb Company (BMY) van 1972 tot 2026
Jaarlijkse dividendbetalingen
Jaar Dividend (aangepast voor aandelensplitsingen) Wijzigen
2026 (TTM) $0.63 -74.60%
2025 $2.48 3.33%
2024 $2.40 5.26%
2023 $2.28 5.56%
2022 $2.16 46.94%
2021 $1.47 -35.81%
2020 $2.29 39.63%
2019 $1.64 2.50%
2018 $1.60 2.56%
2017 $1.56 36.84%
2016 $1.14 -23.49%
2015 $1.49 2.76%
2014 $1.45 -17.61%
2013 $1.76 29.41%
2012 $1.36 3.03%
2011 $1.32 37.50%
2010 $0.96 -23.20%
2009 $1.25 -19.35%
2008 $1.55 38.39%
2007 $1.12 0.00%
2006 $1.12 0.00%
2005 $1.12 33.33%
2004 $0.84 -25.00%
2003 $1.12 -20.00%
2002 $1.40 32.06%
2001 $1.06 13.65%
2000 $0.9328 13.84%
1999 $0.8194 47.16%
1998 $0.5568 -23.52%
1997 $0.728 -18.64%
1996 $0.8948 69.37%
1995 $0.5283 -39.34%
1994 $0.8709 27.10%
1993 $0.6852 39.10%
1992 $0.4926 -16.87%
1991 $0.5926 13.72%
1990 $0.5211 7.87%
1989 $0.4831 -6.85%
1988 $0.5186 107.52%
1987 $0.2499 16.72%
1986 $0.2141 -4.25%
1985 $0.2236 17.44%
1984 $0.1904 9.43%
1983 $0.174 43.80%
1982 $0.121 14.15%
1981 $0.106 48.46%
1980 $0.0714 -16.59%
1979 $0.0856 18.23%
1978 $0.0724 10.37%
1977 $0.0656 22.39%
1976 $0.0536 9.16%
1975 $0.0491 8.63%
1974 $0.0452 -6.03%
1973 $0.0481 170.22%
1972 $0.0178 0.00%
Lijst van alle dividendbetalingen
Jaar Dividend Wijzigen
2026 (TTM) $0.63 -74.60%
2025 $2.48 3.33%
2024 $2.40 5.26%
2023 $2.28 5.56%
2022 $2.16 46.94%
2021 $1.47 -35.81%
2020 $2.29 39.63%
2019 $1.64 2.50%
2018 $1.60 2.56%
2017 $1.56 36.84%
2016 $1.14 -23.49%
2015 $1.49 2.76%
2014 $1.45 -17.61%
2013 $1.76 29.41%
2012 $1.36 3.03%
2011 $1.32 37.50%
2010 $0.96 -23.20%
2009 $1.25 -19.35%
2008 $1.55 38.39%
2007 $1.12 0.00%
2006 $1.12 0.00%
2005 $1.12 33.33%
2004 $0.84 -25.00%
2003 $1.12 -20.00%
2002 $1.40 27.27%
2001 $1.10 12.24%
2000 $0.98 -8.84%
1999 $1.08 -8.12%
1998 $1.17 -23.53%
1997 $1.53 -59.31%
1996 $3.76 69.37%
1995 $2.22 -39.34%
1994 $3.66 27.08%
1993 $2.88 39.13%
1992 $2.07 -16.87%
1991 $2.49 13.70%
1990 $2.19 7.88%
1989 $2.03 -6.88%
1988 $2.18 55.71%
1987 $1.40 -22.22%
1986 $1.80 -4.26%
1985 $1.88 17.50%
1984 $1.60 -20.99%
1983 $2.03 -0.49%
1982 $2.04 14.33%
1981 $1.78 48.33%
1980 $1.20 -16.67%
1979 $1.44 18.03%
1978 $1.22 -11.27%
1977 $1.38 -23.61%
1976 $1.80 9.09%
1975 $1.65 8.55%
1974 $1.52 -6.17%
1973 $1.62 170.00%
1972 $0.6 0.00%
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
Bedrijf Aantal dividendbetalingen Land
215.00%
US
225.00%
US
53.00%
US
33.00%
CH
223.00%
US